| Identification | Back Directory | [Name]
PI-3065 | [CAS]
955977-50-1 | [Synonyms]
129556
PI-306
CS-1274
PI-3065
PI-3065|PI3065
PI-3065, >=98%
PI-3065 USP/EP/BP
4-(6-((4-(Cyclopropylmethyl)piperazin-1-yl)methyl)-2-(5-fluoro-1H-indol-4-yl)thieno[3,2-d]pyri
6-((4-(cyclopropylmethyl)piperazin-1-yl)methyl)-2-(5-fluoro-1H-indol-4-yl)-4-morpholinothieno[3,2-d]pyrimidine
6-(4-CyclopropylMethyl-piperazin-1-ylMethyl)-2-(5-fluoro-1H-indol-4-yl)-4-Morpholin-4-yl-thieno[3,2-d]pyriMidine
4-(6-((4-(cyclopropylmethyl)piperazin-1-yl)methyl)-2-(5-fluoro-1H-indol-4-yl)thieno[3,2-d]pyrimidin-4-yl)morpholine
6-[[4-(Cyclopropylmethyl)-1-piperazinyl]methyl]-2-(5-fluoro-1H-indol-4-yl)-4-(4-morpholinyl)-thieno[3,2-d]pyrimidine
Thieno[3,2-d]pyrimidine, 6-[[4-(cyclopropylmethyl)-1-piperazinyl]methyl]-2-(5-fluoro-1H-indol-4-yl)-4-(4-morpholinyl)-
6-(4-CyclopropylMethyl-piperazin-1-ylMethyl)-2-(5-fluoro-1H-indol-4-yl)-4-Morpholin-4-yl-thieno[3,2-d]pyriMidine PI-3065 | [Molecular Formula]
C27H31FN6OS | [MDL Number]
MFCD28167771 | [MOL File]
955977-50-1.mol | [Molecular Weight]
506.638 |
| Chemical Properties | Back Directory | [density ]
1.372±0.06 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,Store in freezer, under -20°C | [solubility ]
≥22.7 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH | [form ]
solid | [pka]
14.80±0.30(Predicted) | [color ]
White to off-white | [InChIKey]
YDNOHCOYQVZOMC-UHFFFAOYSA-N | [SMILES]
C1(C2=C(F)C=CC3=C2C=CN3)=NC(N2CCOCC2)=C2SC(CN3CCN(CC4CC4)CC3)=CC2=N1 | [CAS DataBase Reference]
955977-50-1 |
| Hazard Information | Back Directory | [Biological Activity]
pi-3065 is a small molecule and selective inhibitor of p110δkinase with an ki value of 1.5nm and ic50 value of 5nm [1].pi-3065 has been reported to selectively inhibit p110δkinase with ki values of 15nm, 110nm, 130nm and 940nm, ic50 values of 5nm, 91nm, 600nm and >10000nm for p110δ, p110α, p110β and p110γ, respectively. in addition, pi-3065 has been revealed to inhibit 4t1 tumour growth and metastasis. pi-3065 has also noted to prolong survival and reduce the incidence of macroscopic metastases and other disease-associated pathologies [1]. | [in vitro]
PI-3065 shows no inhibition on the growth of 4T1 cells, which do not expressing detectable levels of p110δ. | [target]
| p110α 910 nM (IC 50 ) | p110β 600 nM (IC 50 ) | p110δ 5 nM (IC 50 ) | | [storage]
Store at -20°C | [References]
[1] ali k1, soond dr2, pi?eiro r1, hagemann t3, pearce w4, lim el5, bouabe h5, scudamore cl6, hancox t7, maecker h8, friedman l8, turner m5, okkenhaug k9, vanhaesebroeck b1. inactivation of pi(3)k p110δ breaks regulatory t-cell-mediated immune tolerance to cancer. nature. 2014 jun 19;510(7505):407-11. doi: 10.1038/nature13444. epub 2014 jun 11. |
|
| Company Name: |
ChemShuttle, Inc.
|
| Telephone: |
0510-83588313-811 18800520310 |
| Website: |
www.jiehuapharma.com/ |
| Company Name: |
LETOPHARM LIMITED
|
| Telephone: |
+86-21-5821 5861 |
| Website: |
www.letopharm.com |
| Company Name: |
SPIRO PHARMA
|
| Telephone: |
|
| Website: |
www.spiropharma.com.cn |
| Company Name: |
Twochem Co.Ltd
|
| Telephone: |
021-021-58111628 15800915896 |
| Website: |
www.twochem.com |
|